Bmi-1 gene is well recognized as an oncogene, but has been recently demonstrated to play a role in the self-renewal of tissue-specific stem cells. By using Bmi-1 GFP/+ mice, we investigated the role of Bmi-1 in cardiac stem/progenitor cells and myocardial repair.
and medulloblastomas. 5 These studies have found that down-regulation of Bmi-1 in cancer stem cells suppresses tumour growth. 3, 6, 7 Beyond its role as an oncogene, up-regulation of Bmi-1 in various tissuespecific stem cells, [8] [9] [10] such as hematopoietic stem cells (HSC), 2, 3, 8 intestinal stem cells, 11 and epithelial stem cells in the pancreatic, prostate, lung, and others, [12] [13] [14] [15] [16] [17] [18] has been demonstrated to play essential roles in the self-renewal and the maintenance of stemness. Reduced expression of Bmi-1 has also recently been found to enhance the beating of cardiomyocytes (CM) induced from neonatal and adult mouse fibroblasts by directly reprogramming. 19 However, little has been known about Bmi-1 expression in cardiac stem/progenitor cells.
Actually, the identity, origin and physiological role of endogenous cardiac stem/progenitor cells in adult mammals are still debated. For a long time, adult mammalian heart was thought to be a terminally differentiated organ. However, considerable evidence has shown the low turnover rate of CM. 20, 21 There are at least two possible resources for the new born CM: preexisting CM 22, 23 or cardiac stem/ progenitor cells. [24] [25] [26] [27] By now, different markers and methods have been applied for the identification and expansion of resident cardiac stem/progenitor cells, such as the c-kit-positive cells, 26 Sca-1-positive cells, 27 cardiac side population (SP), 24 and cardiosphere derived cells. 28 Using an inducible genetic labelling approach, we have recently defined cardioblasts, the small non-myocyte cells express cardiac transcription factors and sarcomeric proteins and form mature CM in vivo after transplantation. 25 Endogenous cardioblasts are rarely evident in the normal adult mouse heart, but will be significantly activated after myocardial infarction. The cardioblasts do not arise from haematogenous seeding, CM dedifferentiation, or mere expansion of a preformed progenitor pool. 25 In this study, we investigated the potential role of Bmi-1 on cardiac stem/progenitor cells by using Bmi-1-GFP-knock-in mice, in which GFP was expressed under the endogenous transcriptional regulatory elements of the Bmi-1 gene, and the levels of Bmi-1 expression in cells could be quantified by GFP fluorescence. 3 We found that the subpopulations of cells with high expression of Bmi-1 in heart tissue enriched in SP and Sca-1-positive cardiac stem/progenitor cells, and showed a significantly increase in number in response to myocardial infarction.
| MATERIALS AND METHODS

| Animals and genotyping
The procedures for all animal experiments were approved by the were observed by GE DeltaVision OMX or Leica TCS SP5 confocal microscopy.
| RNAi and RT-qPCR
Bmi-1 and the negative control siRNA duplexes were transfected into primary non-CM cells using riboFECT ™ CP ( 
| Myocardial infarction model
To further investigate how the Bmi-1 expression will be changed in response to heart injury, myocardial infarction was made in Bmi-1 After removing the pericardium, LAD was ligated with 7-0 silk suture under direct vision of surgical microscopy. Mice received a left thoracotomy alone were used for control. All mice survived after the successful surgical procedures, and no mouse died during the follow-up period.
Six mice from each group were euthanized 1 week after surgery, and the heart for evaluating the subpopulation of cells with high expression of Bmi-1 by flow cytometry as described above. Another three mice from each group were euthanized 2 weeks after surgery, and excised hearts were snap-frozen for histological analysis, and cryosections (10 μm) were stained following standard procedures. Images of histological staining were taken using Olympus microscope. All analyses were conducted by individuals blind to treatment allocation.
| Statistical analysis
Data and statistical analysis were done by GraphPad Prism 6.0.
Results are presented as mean ± SEM unless specified otherwise.
Comparisons between any two groups were performed with twotailed unpaired Student's t-test. Each experiment was performed at least three times and the differences were considered statistically significant when P < 0.05. Figure S1 ).
We next examined whether Bmi-1 will be also highly expressed in cardiac stem/progenitor cells. Because almost all GFP + cells were Bmi-1 + and 96.69% ± 2.61% of Bmi-1 + heart cells expressed GFP through immunofluorescent images (Figure 2A) Figure 2B ). We found that the Bmi-1 expression was significantly higher in SP cells than in MP cells ( Figure 2C ). We also tried to gate CD45 − Ter119 − CD31 − SP cells by flow cytometry, and then measured the Bmi-1 expression by fluorescence intensity.
We could observe more Bmi-1 GFP hi cells in SP population than MP population (3.73 ± 0.76% vs 1.10 ± 0.38%, P < 0.05; Figure 2D ). 7.82 ± 2.77%, P < 0.05; Figure 2F ).
Sca
So, our data from BM and heart cells indicated that Bmi-1 GFP hi subpopulation enriched not only in HSC but also in cardiac stem/progenitor cells. Although cardiac-specific Bmi-1 deletion during embryogenesis does not affect cardiogenesis, 32 it has been reported that quercetin could minimize doxorubicin-induced cardiotoxicity by modulating Bmi-1 expression. 33 There is very limited information on the role of Bmi-1 expression in cardiac stem/progenitor cells. By using
Bmi-1-GFP-knock-in mice, 3 we found that the expression with high 34 and myocardial repair following acute injury. 35 Furthermore, Bmi-1 expression is associated with reactive oxygen species levels. 36 But we made a more detailed distinction. In this study, we The proportion of cTnT + cardiomyocytelike cells was at 5 days after TSA treatments. NC: negative control. *P < 0.05; **P < 0.005; ***P < 0.001
identification of cardiac stem/progenitor cells. Second, it is impossible for us to exactly quantify the Bmi-1 hi cells in the whole heart because we collected these small size heart cells for analysis by removing the CM. Third, we do not know whether the subpopulations of small size heart cells with the expression of Bmi-1 at intermediate and low levels are actually generated from these Bmi-1 hi cells followed by a gradually reduction of Bmi-1 expression during the differentiation process. 3 Finally, it is hard for us to collect enough number of Bmi-1 hi heart cells for in vivo implantation into a damaged heart. The role of Bmi-1 is also required to investigate in vivo by using Bmi-1 knockout animals. So, the role of Bmi-1 hi heart cells for functional myocardial repair is still questionable.
In summary, Bmi-1 was expressed higher in cardiac SP than MP 
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